Stockreport

Daiichi Sankyo's ADC Alliances Test Valuation Gap In Oncology Strategy [Yahoo! Finance]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF Daiichi Sankyo Company (TSE:4568) has entered a collaboration with Tempus AI to apply AI models to patient selection and biomarker discovery in oncology. The company [Read more]